Jul 7, 2008
Antisoma PLC Early Findings Show Promise as AS1411 AML Study Proceeds to Higher-Dose Stage
Antisoma PLC Early Findings Show Promise as AS1411 AML Study Proceeds to Higher-Dose Stage 7/7/2008 London, UK: 07 July 2008 - Cancer drug developer Antisoma plc today announces initial findings from its phase ...
Read full story from BioSpace
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Merck to fund Vioxx settlement in August | 1 hr | DJ -SMD | 1319 |
| MPI Research cutting jobs in Mattawan | 3 hr | Harold | 5 |
| Claims administrator: Interim payments in $4.85... | 3 hr | heraldo | 983 |
| Buffalo - The Next Cleveland? | 4 hr | Wow | 14 |
| Cymbalta leads the way for Lilly (from Feb '07) | 4 hr | edd | 232 |
| Vioxx claimants rush to join $4.85B settlement ... (from Jan '08) | 5 hr | IronLady | 647 |
| Teva Announces Launch of Generic Zoloft (from Nov '06) | 7 hr | KGH Monroe NC | 1113 |
Scorpio
Most Popular
